Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer (THE TAX 324 trial)

被引:0
|
作者
Prasanth, G. [1 ]
Sharma, Atul [1 ]
机构
[1] AIIMS, Inst Rotary Canc Hosp, Dept Med Oncol, New Delhi 110029, India
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:23 / 25
页数:3
相关论文
共 50 条
  • [1] Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer
    Posner, Marshall R.
    Hershock, Diane M.
    Blajman, Cesar R.
    Mickiewicz, Elizabeth
    Winquist, Eric
    Gorbounova, Vera
    Tjulandin, Sergei
    Shin, Dong M.
    Cullen, Kevin
    Ervin, Thomas J.
    Murphy, Barbara A.
    Raez, Luis E.
    Cohen, Roger B.
    Spaulding, Monica
    Tishler, Roy B.
    Roth, Berta
    del Carmen Viroglio, Rosana
    Venkatesan, Varagur
    Romanov, Ilya
    Agarwala, Sanjiv
    Harter, K. William
    Dugan, Matthew
    Cmelak, Anthony
    Markoe, Arnold M.
    Read, Paul W.
    Steinbrenner, Lynn
    Colevas, A. Dimitrios
    Norris, Charles M., Jr.
    Haddad, Robert I.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (17): : 1705 - 1715
  • [2] Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer
    Vermorken, Jan B.
    Remenar, Eva
    van Herpen, Carla
    Gorlia, Thierry
    Mesia, Ricard
    Degardin, Marian
    Stewart, John S.
    Jelic, Svetislav
    Betka, Jan
    Preiss, Joachim H.
    van den Weyngaert, Danielle
    Awada, Ahmad
    Cupissol, Didier
    Kienzer, Heinz R.
    Rey, Augustin
    Desaunois, Isabelle
    Bernier, Jacques
    Lefebvre, Jean-Louis
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (17): : 1695 - 1704
  • [3] Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial
    Lorch, Jochen H.
    Goloubeva, Olga
    Haddad, Robert I.
    Cullen, Kevin
    Sarlis, Nicholas
    Tishler, Roy
    Tan, Ming
    Fasciano, John
    Sammartino, Daniel E.
    Posner, Marshall R.
    LANCET ONCOLOGY, 2011, 12 (02): : 153 - 159
  • [4] A comparison of cisplatin and fluorouracil alone or with docetaxel in squamous cell carcinoma of the head and neck
    Ho, K.
    Slevin, N.
    NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (06): : 306 - 307
  • [5] A comparison of cisplatin and fluorouracil alone or with docetaxel in squamous cell carcinoma of the head and neck
    Kean Ho
    Nick Slevin
    Nature Clinical Practice Oncology, 2008, 5 : 306 - 307
  • [6] Docetaxel, cisplatin, fluorouracil, and leucovorin in locally advanced head and neck cancer
    Janinis, J
    Panagos, G
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (06) : 1393 - 1394
  • [7] Docetaxel, cisplatin, fluorouracil, and leucovorin in locally advanced head and neck cancer -: In reply
    Colevas, AD
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (06) : 1394 - 1395
  • [8] Quality of Life of Patients with Head and Neck Cancer Receiving Cetuximab, Fluorouracil, Cisplatin Comparing to Cetuximab, Fluorouracil, Cisplatin, and Docetaxel within the CEFCID Trial
    Goerling, Ute
    Gauler, Thomas
    Dietz, Andreas
    Gruenwald, Viktor
    Knipping, Stephan
    Guntinas-Lichius, Orlando
    Frickhofen, Norbert
    Lindeman, Hans-Walter
    Fietkau, Rainer
    Haxel, Boris
    Grosse-Thie, Christina
    Maschmeyer, Georg
    Zipfel, Matthias
    Martus, Peter
    Knoedler, Maren
    Keilholz, Ulrich
    Klinghammer, Konrad
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (06) : 319 - 324
  • [9] Docetaxel and cisplatin in head and neck cancer
    Schöffski, P
    Wanders, J
    Verweij, J
    Fumoleau, P
    ANNALS OF ONCOLOGY, 2000, 11 (12) : 1617 - 1617
  • [10] Toxicity of induction chemotherapy with docetaxel, cisplatin, & 5-fluorouracil for advanced head and neck cancer
    Billan, Salem
    Kaidar-Person, Orit
    Atrash, Fadi
    Doweck, Ilana
    Haim, Nissim
    Kuten, Abraham
    Ronen, Ohad
    TUMOR BIOLOGY, 2012, 33 : 77 - 78